Progyny, Inc. (PGNY) Stock Forecast
PGNY analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.58 / 5 from 12 analysts
- Price target
- $34.42 average of analyst targets
- Upside to target
- +28.1% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.27
- 52-week range
- $16.30 – $32.36
PGNY analyst ratings
12 analystsNumber of analysts at each rating.
PGNY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PGNY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.51 | $0.49 | $0.53 | $0.45 | +13.1% | 8 |
| Current fiscal year (2026) | $2.08 | $2.06 | $2.10 | $1.89 | +10.3% | 8 |
| Next fiscal year (2027) | $2.31 | $2.18 | $2.47 | $2.08 | +10.9% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PGNY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $340.8M | $336.5M | $344.6M | +8.8% | 10 |
| Current fiscal year (2026) | $1.38B | $1.36B | $1.39B | +6.7% | 10 |
| Next fiscal year (2027) | $1.52B | $1.47B | $1.57B | +10.2% | 10 |
PGNY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PGNY revenue: reported and forecast
PGNY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.52 | $0.51 | $0.51 | $0.51 | $0.51 | −2.7% | 1 up · 6 down |
| Current fiscal year (2026) | $2.06 | $2.08 | $2.08 | $2.08 | $2.08 | +1.4% | 8 up · 0 down |
| Next fiscal year (2027) | $2.25 | $2.30 | $2.32 | $2.32 | $2.31 | +2.9% | 7 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PGNY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PGNY beat in 12 of 12.
What analysts expect from PGNY
12 analysts cover Progyny; their consensus rating is strong buy (4.58 on a 1–5 scale, where 5 is a strong buy). The average price target is $34.42, 28.1% above the latest close of $26.86. Analysts expect earnings of $2.08 per share for 2026, +10.3% from a year earlier. For 2027 the average estimate is $2.31 per share on revenue of $1.5 billion. Progyny beat the EPS estimate in 12 of the last 12 quarters.
Related: PGNY income statement, PGNY key metrics, PGNY chart. See the PGNY stock overview for the latest quote and news.
PGNY forecast FAQ
What is Progyny's price target?
The average analyst price target for Progyny is $34.42, 28.1% above the latest close of $26.86.
Is Progyny a buy, hold or sell?
Of 12 analysts covering Progyny, 9 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Progyny's EPS forecast?
Analysts forecast $2.08 per share for 2026 (range $2.06 to $2.10); for 2027 the estimate is $2.31.
What is Progyny's revenue forecast?
The average revenue estimate for 2026 is $1.4 billion, growth of 6.7%; for 2027 it is $1.5 billion.
When does Progyny report earnings?
Progyny is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.27.
Does Progyny usually beat earnings estimates?
Progyny reported EPS at or above the analyst estimate in 12 of the last 12 quarters.